- CNBC•yesterday
Suze Orman says this is how much money you should have in your emergency fund
If you're trying to get your financial house in order, any number of experts will tell you the same thing: Build up an emergency fund of at least three to six months' worth of living expenses. "They're idiots," Orman said at the 2017 eMerge Americas conference, answering a question about how much to keep in your emergency fund. A million potential scenarios could drain your savings without warning, so it's better to have at least eight to 12 months' worth of living expenses squirreled away.
Business Insider•18 hours agoThe mysterious trader known as '50 Cent' appears to be back betting on more stock market chaos
The mysterious volatility trader known as "50 Cent" appears to have made some new bets this week that the stock market will see turbulence over the summer. The trades match a growing sentiment across Wall Street that the stock market could be in for a rocky ride over the next few months. Known for his consistent purchases of bite-size Cboe Volatility Index (VIX) options — usually costing about 50 cents — the trader has historically positioned himself to profit from market turbulence.
- MarketWatch•1 hour ago
Nvidia to replace Time Warner in S&P 100
Nvidia Corp. will replace Time Warner Inc. in the S&P 100 index prior to the opening bell on June 20, S&P Dow Jones Indices said late Friday. Nvdia stock was flat in after hours trading and closed down 0.6% to $265.26 during the regular session. The
- Bloomberg•3 hours ago
Theranos Founder Holmes Is Out as CEO of Scandal-Ridden Startup
Elizabeth Holmes, who founded blood-testing company Theranos Inc. only to watch it unravel amid revelations that her main product was a fraud, has stepped down as chief executive officer. After the testing device that Holmes claimed would be able run hundreds of medical tests on a single drop of blood was shown not to work, Holmes was barred from running a clinical company by U.S. regulators, was sued by investors, and the company let go many of its employees. Holmes will keep her role as chair of the board, Theranos said in a statement Friday.
- Bloomberg•5 hours ago
China Targets U.S. Farm Imports With Tariffs on Soybeans, Corn
Trade tensions between the U.S. and China ratcheted higher after the Asian nation said it will follow through on plans to levy tariffs on a range of American farm goods including soybeans and corn. An additional 25 percent tariff will levied on about $50 billion of U.S. imports, China’s Ministry of Finance said Saturday in a statement on its website. Tariffs on about $34 billion of those imports will start July 6, covering agricultural products including: soy, corn, wheat, rice, sorghum, beef, pork, poultry, fish, dairy products, nuts and vegetables.
- InvestorPlace•3 hours ago
Investors Should Follow Buffett Into Phillips 66 Stock
Warren Buffett clearly knows his way around the stock market. There’s no reason to go over America’s favorite value investor’s history of great returns and generating gains for Berkshire Hathaway (NYSE:BRK.A, NYSE:BRK.B). The key for Buffett’s and Berk’s success comes down to buying companies with large economic moats that generate huge amounts of rising cash flows.
- InvestorPlace•7 hours ago
General Electric Company’s Dividend Will Be Fine … Probably
Just a few days ago, J.P. Morgan analyst Stephen Tusa suggested industrial giant General Electric Company (NYSE:GE) should be — if it wasn’t — mulling the possibility of yet another dividend cut. Of all the ways the company could allocate its operating cash flow in its present situation, sustaining the dividend payout seems to make the least mathematical sense.
- InvestorPlace•6 hours ago
3 of the Best AI Stocks to Buy Right Now
Remember when cloud computing became the hot new buzzword on Wall Street? While this industry continues to expand, another new term is being spun around financial blogs, Twitter Inc (NYSE:TWTR) and weekly magazines: artificial intelligence. First thing’s first: artificial intelligence uses machine learning, deep learning and other processes that allow computers to perform tasks that generally require human intelligence.
InvestorPlace•9 hours agoJust Stop Worrying Already and Buy Bank of America Corp Stock
Last year was a good great one for Bank of America Corp (NYSE:BAC) shareholders. BAC stock was up a little more than 40% in 2017, following 2016’s 60% advance. While the market’s up roughly 4% year-to-date thanks to the recent recovery, BAC stock is barely at a break-even, with shares of the mega-bank simply not riding the recent bullish wave.
- CNBC Videos•11 hours ago
AT&T CEO: We’ll launch free mobile 'skinny' bundle next w...
Randall Stephenson, AT&T Chairman and CEO, speaks with CNBC's "Squawk Box" following the telecom giant's big court victory in its merger with Time Warner.
- Zacks•10 hours ago
Here's Why You Should Dump Pentair (PNR) From Your Portfolio
If you are still holding on to shares of Pentair plc PNR in your portfolio, it is time you dump those as chances of favorable returns in the near term appear bleak. Pentair has witnessed a significant price decline in the year-to-date period owing to material and other cost inflation as well as headwinds pertaining to the separation of the Electrical business. Further, the company’s Zacks Rank #5 (Strong Sell) only reflects its innate weakness.
InvestorPlace•9 hours agoOK, I’ll Say It. Advanced Micro Devices, Inc. Stock Is Beyond Overextended
AMD stock is up at least 30% for you, and if you stepped in at the early April low, you’re sitting on 66% gain. Advanced Micro Devices shares may look and feel red hot right now, but the rally’s carried AMD stock a little too far, too fast, and a pullback is nigh.
- CNBC Videos•yesterday
These are the surging tech stocks to buy right now, techn...
3 tech stocks to buy at highs. With Todd Gordon, TradingAnalysis.com, CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, David Seaburg, Brian Kelly and Guy Adami.
- Zacks•9 hours ago
Upcoming Tech Earnings to Watch: ORCL, MU, RHT
Investors shrugged their shoulders at the Fed's slightly more hawkish outlook on future rate hikes this week after positive news from the ECB and great macroeconomic data in the U.S. underscored the strength of the global economy. A great first quarter earnings season for the sector was met with lukewarm reactions, but volatility has eased and tech companies are all the rage once again. Using the Earnings Calendar, we looked ahead to next week and selected the top reports from the technology sector to watch.
- Zacks•10 hours ago
New Strong Sell Stocks for June 15th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:AMN Healthcare Services, Inc. AMN is a provider of healthcare workforce solutions and staffing services. The Zacks Consensus Estimate for its current year earnings has been revised
- Bloomberg•2 days ago
Royal Caribbean Has a $240,000 Cruise for You
If you have a quarter of a million dollars to spare, Royal Caribbean Cruises Ltd. will soon have a vacation for you. The Miami-based cruise operator agreed to buy a 66.7 percent stake in closely held Silversea Cruises Ltd. based on an enterprise value of about $2 billion. The deal will give the company new luxury offerings, including a stay in the Owner’s Suite that starts at $240,000 per person for Silversea’s World Cruise 2020, a 140-day trip around the globe.
- TheStreet.com•yesterday
Four Stocks Poised for Big Gains: Cramer's 'Off the Charts'
With a stock market that's been picking up steam for quite some time, finding reasonable places to invest is challenging. Moreno has several picks he feels are ready to move higher, starting with United States Steel Corp. The steelmaker's stock has been trading sideways despite President Trump's imposition of steel tariffs on imports.
- TheStreet.com•yesterday
9 Stocks Goldman Sachs Thinks Will Blow Wall Street's Performance Away in 2019
2018 is just about over, in the minds of some investors. "We expect investors will soon look past 2018 and focus on 2019 growth," says Goldman Sachs strategist David Kostin. "For many years, beginning in July investors would start to value stocks
- TheStreet.com•8 hours ago
3 Fierce Chinese Tech Stocks to Trade Right Now
Don't be scared to trade China. As the trade war volatility escalates between the U.S. and China, Trump has added more fuel to fire with his latest offensive to 'restrict control exports of industrially significant technology'. Chinese e-commerce powerhouse Alibaba has eclipsed the headlines for all the right reasons.
InvestorPlace•yesterdayShould You Buy These 3 Red-Hot Chinese Stocks?
Chinese stocks have been hot over the past few weeks, turning a lot of investors’ heads. While Alibaba Group Holding Ltd (NYSE:BABA) breaking to new highs and JD.Com Inc(ADR) (NASDAQ:JD) ripping higher from critical support have been promising, a new
- Zacks•12 hours ago
ExxonMobil (XOM) to Construct Pipeline in Crowded Permian
Exxon Mobil Corporation XOM intends to construct a pipeline in the Permian Basin, in line with its plan to allocate more than $2 billion for midstream asset expansions in the crowded shale play. The largest publicly traded integrated energy firm along with Plains All American Pipeline (“PAA) will likely invest billions of dollars for building a pipeline that will transport crude to the Gulf coast region from the Permian Basin. The Permian faces a dearth of pipeline capacity for transporting oil to Gulf Coast export facilities, major refinery terminals and principal hubs like Cushing.
- Investor's Business Daily•10 hours ago
Avalara IPO Prices Above High End Of Range, Raises $180 Million
Cloud software company Avalara (AVLR) priced its initial public offering late Thursday at 24, above an upwardly revised range of 21 to 23 and raising $180 million. The stock is to trade on the New York Stock Exchange on Friday morning under the ticker AVLR. Institutional investors showed strong interest in the IPO, pushing the price up from an initial range of 19 to 21.
- Zacks•11 hours ago
Zacks Value Investor Highlights: Gilead Sciences, Biogen, Celgene, Lannett and Valeant
June 15, 2018 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio service, shares some of her top value investing tips and stock picks. Recently, investors on Stocktwits and Twitter have been asking about some of the drug stocks.
- Barrons.com•9 hours ago
Big Biotech Set for Earnings Blowout?
Earlier this year, Oppenheimer's Hartaj Singh argued that earnings expectations were too high for big biotech companies heading into the first-quarter reporting season. Ahead of the reports, due out in mid-July, Singh argues that fundamentals for large-cap biotech, as well as sector sentiment are "slowly but surely improving," leading him to believe that the stocks could outperform, led by Gilead Sciences (GILD), Alexion Pharmaceuticals (ALXN), and Vertex Pharmaceuticals (VRTX). For Gilead, he's upbeat about a more stable pricing environment for hepatitis C treatments, while investors are getting more interested in the company's "budding" immunology and nonalcoholic steatohepatitis (NASH) franchises, setting up an attractive risk-reward profile going into the second quarter. Alexion reported "stellar" first-quarter earnings, and Singh sees another strong quarter ahead, and he wonders "when the Street will start giving management credit for relentless execution." Vertex is one of his favorite large-cap biotechs, and he sees a good report ahead, along with an update about the progress of its cystic-fibrosis drugs.
- InvestorPlace•7 hours ago
The Issue That Will Bring Twitter Inc Back to Earth
Micro-blogging social media company Twitter Inc (NYSE:TWTR) has seen an impressive rally over the past year. TWTR stock rose to $45 per share in a matter of months after investors started to see some potential from the little blue bird when it finally returned to profitability during the final quarter of 2017. While some are calling for TWTR to make its way above $50, I’m not so optimistic.
